Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
Prestige Consumer Healthcare has scheduled its fiscal 2025 fourth quarter and year-end earnings announcement for Thursday, May 8, 2025, before market opening.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Prestige Consumer Healthcare has scheduled its fiscal 2025 fourth quarter and year-end earnings announcement for Thursday, May 8, 2025, before market opening. The company will follow this with a conference call at 8:30 a.m. ET on the same day.
Stakeholders can participate in two ways:
- Through a live Internet webcast accessible via the Investor Relations page at prestigeconsumerhealthcare.com
- Via phone conference by registering online to receive dial-in details and a unique pin
For those joining by phone, it is recommended to connect 10 minutes before the event starts. A replay of the conference call will be available for approximately one week after the event and can be accessed through the company's Investor Relations webpage.
Positive
- Timely financial reporting with Q4 and year-end earnings scheduled for May 8, 2025
- Company maintains transparent investor communication through live webcast and conference call
Negative
- None.
Details
News Market Reaction – PBH
The recorded move for PBH in the trading session of this news was +1.75%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.